Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2010-1-21
pubmed:abstractText
Various studies in mice have found support for the hypothesis that heterozygous carriers of cystic fibrosis transmembrane conductance regulator (CFTR) mutations have an increased resistance to fatal infection compared to both homozygous mutation carriers and non-carriers, while in humans such evidence is scarce. In this study, we assessed the CFTR heterozygotes survival advantage hypothesis in a contemporary rural population that lives under adverse environmental conditions in the Upper-East region of Ghana. We genotyped 30 SNPs throughout the CFTR gene in 4,230 participants and tested their influence on survival and on body composition in the population at large. With a sliding-window haplotype analysis, we identified a set of six common haplotypes that influenced survival probabilities (global p = 6.00 x 10(-05)). Individual haplotype analyses revealed two haplotypes of specific interest. One of these haplotypes was enriched (p = 0.003), whereas the other was depleted (p = 0.041) among people of old age (> or = 65 years) compared to young study participants (< or = 5 years). In addition, children (n = 474) carrying the latter haplotype had lower body weight (p (trend) = 0.020) and height (p (trend) = 0.010) compared to non-carriers. For all these analyses, similar associations for heterozygous and homozygous CFTR haplotype carriers were observed, revealing an additive effect of haplotype alleles. In conclusion, we identified common haplotypes in the CFTR gene that influence survival and body composition in the population at large with no evidence for heterozygote advantage.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19890664-11055897, http://linkedlifedata.com/resource/pubmed/commentcorrection/19890664-11168023, http://linkedlifedata.com/resource/pubmed/commentcorrection/19890664-11791212, http://linkedlifedata.com/resource/pubmed/commentcorrection/19890664-15297300, http://linkedlifedata.com/resource/pubmed/commentcorrection/19890664-16078047, http://linkedlifedata.com/resource/pubmed/commentcorrection/19890664-17015291, http://linkedlifedata.com/resource/pubmed/commentcorrection/19890664-18079549, http://linkedlifedata.com/resource/pubmed/commentcorrection/19890664-18990415, http://linkedlifedata.com/resource/pubmed/commentcorrection/19890664-19178922, http://linkedlifedata.com/resource/pubmed/commentcorrection/19890664-19242412, http://linkedlifedata.com/resource/pubmed/commentcorrection/19890664-19431193, http://linkedlifedata.com/resource/pubmed/commentcorrection/19890664-3369446, http://linkedlifedata.com/resource/pubmed/commentcorrection/19890664-7113955, http://linkedlifedata.com/resource/pubmed/commentcorrection/19890664-7524148, http://linkedlifedata.com/resource/pubmed/commentcorrection/19890664-7529941, http://linkedlifedata.com/resource/pubmed/commentcorrection/19890664-8539601, http://linkedlifedata.com/resource/pubmed/commentcorrection/19890664-8825494, http://linkedlifedata.com/resource/pubmed/commentcorrection/19890664-8880589, http://linkedlifedata.com/resource/pubmed/commentcorrection/19890664-9496182, http://linkedlifedata.com/resource/pubmed/commentcorrection/19890664-9590693, http://linkedlifedata.com/resource/pubmed/commentcorrection/19890664-9950364
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1432-1203
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
127
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
201-6
pubmed:dateRevised
2010-9-28
pubmed:meshHeading
pubmed-meshheading:19890664-Adolescent, pubmed-meshheading:19890664-Adult, pubmed-meshheading:19890664-Aged, pubmed-meshheading:19890664-Body Composition, pubmed-meshheading:19890664-Child, pubmed-meshheading:19890664-Child, Preschool, pubmed-meshheading:19890664-Cystic Fibrosis Transmembrane Conductance Regulator, pubmed-meshheading:19890664-Female, pubmed-meshheading:19890664-Gene Frequency, pubmed-meshheading:19890664-Genetic Variation, pubmed-meshheading:19890664-Genotype, pubmed-meshheading:19890664-Ghana, pubmed-meshheading:19890664-Haplotypes, pubmed-meshheading:19890664-Humans, pubmed-meshheading:19890664-Infant, pubmed-meshheading:19890664-Infant, Newborn, pubmed-meshheading:19890664-Linear Models, pubmed-meshheading:19890664-Linkage Disequilibrium, pubmed-meshheading:19890664-Male, pubmed-meshheading:19890664-Middle Aged, pubmed-meshheading:19890664-Polymorphism, Single Nucleotide, pubmed-meshheading:19890664-Rural Population, pubmed-meshheading:19890664-Socioeconomic Factors, pubmed-meshheading:19890664-Time Factors, pubmed-meshheading:19890664-Young Adult
pubmed:year
2010
pubmed:articleTitle
Common CFTR gene variants influence body composition and survival in rural Ghana.
pubmed:affiliation
Department of Gerontology and Geriatrics, Leiden University Medical Center (LUMC), C2-R, PO Box 9600, 2300 RC Leiden, The Netherlands. M.Kuningas@lumc.nl
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't